Home › Funds › CONWAY CAPITAL MANAGEMENT, INC. › EW

CONWAY CAPITAL MANAGEMENT, INC. position in EW

EDWARDS LIFESCIENCES CORP · Health Care

CONWAY CAPITAL MANAGEMENT, INC. reported holding 10,550 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$911K, representing 0.39% of its reported portfolio and ranking #28 among its reported holdings. CONWAY CAPITAL MANAGEMENT, INC. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.55K sh
Reported value held$910.68K
Portfolio Weight0.39%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CONWAY CAPITAL MANAGEMENT, INC.'s EW position evolved

CONWAY CAPITAL MANAGEMENT, INC. first disclosed a stake in EW in Q3 2023 at 16,900 shares (US$1.2M). The position peaked in Q1 2024 at 15,625 shares, worth US$1.5M. Across 13 filings, CONWAY CAPITAL MANAGEMENT, INC. increased the stake 0 time(s), trimmed it 6 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 10,550 shares valued at US$911K. Notable position changes include a 28% trim in Q3 2024 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.90K $1.17M New
Q4 2023 16.23K $1.24M Reduce
Q1 2024 15.62K $1.49M Reduce
Q2 2024 15.62K $1.44M Hold
Q3 2024 11.18K $737.44K Reduce
Q4 2024 11.18K $827.28K Hold
Q1 2025 11.14K $807.79K Hold
Q2 2025 11.14K $871.65K Hold
Q3 2025 11.14K $866.75K Hold
Q4 2025 10.89K $928.80K Reduce
Q1 2026 10.64K $852.45K Reduce
Q2 2026 10.55K $954.35K Reduce
Q3 2026 10.55K $910.68K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has CONWAY CAPITAL MANAGEMENT, INC. held EW?

CONWAY CAPITAL MANAGEMENT, INC. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CONWAY CAPITAL MANAGEMENT, INC.'s current position in EW?

As of Q3 2026, CONWAY CAPITAL MANAGEMENT, INC. holds 10.55K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $910.68K, representing 0.39% of its reported portfolio and ranking #28.

Has CONWAY CAPITAL MANAGEMENT, INC. been buying or selling EW?

In the latest 13F filing (Q3 2026), CONWAY CAPITAL MANAGEMENT, INC. held unchanged its position in EW. The position peaked in Q1 2024 at 15.62K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.